Hispolon (Phellinus)
Hispolon is a phenolic compound derived from Phellinus species mushrooms that demonstrates potent anti-cancer activity through apoptosis induction and cell cycle arrest. This bioactive compound also exhibits significant anti-inflammatory and antioxidant properties by modulating cytokine production and neutralizing reactive oxygen species.
Origin & History
Hispolon is a bioactive compound extracted from the Phellinus mushroom, which grows on trees in tropical and subtropical regions.
Historical & Cultural Context
Phellinus mushrooms have been used in traditional medicine systems in Asia for their purported health benefits, including longevity and vitality.
Health Benefits
- Exhibits anti-cancer properties by inducing apoptosis in cancer cells, aiding in cancer prevention and treatment. - Reduces inflammation by inhibiting pro-inflammatory cytokines, which helps in managing chronic inflammatory diseases. - Provides antioxidant protection by neutralizing free radicals, reducing oxidative stress and cellular damage. - Supports liver health by enhancing detoxification processes and protecting against liver damage. - Boosts immune function by enhancing the activity of macrophages and natural killer cells, crucial for pathogen defense. - Promotes cardiovascular health by lowering cholesterol levels and reducing the risk of heart disease. - Enhances skin health by promoting collagen synthesis, leading to improved skin elasticity and reduced signs of aging.
How It Works
Hispolon induces cancer cell apoptosis through p53 pathway activation and mitochondrial membrane potential disruption, leading to caspase cascade activation. The compound inhibits pro-inflammatory cytokines including TNF-α and IL-6 via NF-κB pathway suppression. Its antioxidant effects stem from direct free radical scavenging and upregulation of endogenous antioxidant enzymes like catalase and superoxide dismutase.
Scientific Research
Studies on Hispolon suggest it has anti-cancer and anti-inflammatory effects, with ongoing research into its mechanisms of action.
Clinical Summary
Research on hispolon consists primarily of in vitro and animal studies, with limited human clinical trials. Laboratory studies demonstrate IC50 values ranging from 10-50 μM against various cancer cell lines including hepatoma and breast cancer cells. Animal studies using doses of 25-100 mg/kg body weight show significant tumor growth inhibition and reduced inflammatory markers. Human clinical evidence remains preliminary, with most benefits extrapolated from preclinical research requiring validation in larger controlled trials.
Nutritional Profile
{"macronutrients": {"protein": "2-3 g per 100 g", "fiber": "1-2 g per 100 g"}, "micronutrients": {"vitamins": {"Vitamin D": "0.2-0.5 \u00b5g per 100 g"}, "minerals": {"Potassium": "200-300 mg per 100 g", "Calcium": "5-10 mg per 100 g"}}, "bioactive_compounds": {"Hispolon": "0.1-0.5 mg per 100 g", "Polysaccharides": "5-10 g per 100 g"}, "bioavailability_notes": "The bioavailability of hispolon and polysaccharides may vary based on preparation methods. Cooking can enhance the bioavailability of certain compounds, while excessive heat may degrade some nutrients."}
Preparation & Dosage
Dosages are not well established; consult a healthcare provider for guidance. Consult a healthcare provider before use.
Synergy & Pairings
PSK, PSP, Erinacine C, Curcumin, Resveratrol
Safety & Interactions
Hispolon appears well-tolerated in animal studies at therapeutic doses, though comprehensive human safety data is limited. No specific drug interactions have been documented, but theoretical interactions may occur with chemotherapy agents due to its anti-cancer mechanisms. Individuals with hormone-sensitive conditions should exercise caution as some phenolic compounds can affect estrogen metabolism. Pregnant and breastfeeding women should avoid hispolon supplements due to insufficient safety data in these populations.